Opportunities and challenges of using circulating tumor DNA to predict lung cancer immunotherapy efficacy. Li S, Yuan T, Yuan J, Zhu B, et al. J Cancer Res Clin Oncol 2024;150:501.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li S, Yuan T, Yuan J, Zhu B, et al. Opportunities and challenges of using circulating tumor DNA to predict lung cancer immunotherapy efficacy. J Cancer Res Clin Oncol 2024;150:501.
PMID: 39545998